Quantitative structure activity relationship study on EC5.0 of anti-HIV drugs

被引:19
|
作者
Si, Hongzong [1 ]
Yuan, Shuping [1 ]
Zhang, Kejun [2 ]
Fu, Aiping [1 ]
Duan, Yun-Bo [1 ]
Hue, Zhide [3 ]
机构
[1] Qingdao Univ, Growing Base State Key Lab, Lab New Fibrous Mat & Modern Text, Inst Computat Sci & Engn, Qingdao 266071, Shandong, Peoples R China
[2] Zhejiang Univ, Dept Comp Sci & Technol, Hangzhou 310027, Zhejiang, Peoples R China
[3] Lanzhou Univ, Dept Chem, Lanzhou 730000, Peoples R China
基金
中国国家自然科学基金;
关键词
gene expression programming (GEP); quantitative structure activity relationship (QSAR); support vector machine (SVM); heuristic method; human immunodeficiency virus (HIV); nucleoside;
D O I
10.1016/j.chemolab.2007.06.011
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
A quantitative model was developed to predict the EC50 of nucleoside by the gene expression programming (GEP). Each kind of compound was represented by several calculated structural descriptors involving constitutional, topological, geometrical, electrostatic and quantum-chemical features of the compound. The GEP method produced a nonlinear quantitative model of the five-descriptor with a correlation coefficient and a mean error of 0.91 and 0.41 for the training set, 0.63 and 0.67 for the test set, respectively. It is shown that the GEP predicted results are in good agreement with experimental ones, better than those of the support vector machine. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:15 / 24
页数:10
相关论文
共 50 条
  • [41] Delivery of anti-HIV drugs - Preface
    Lee, YH
    Sinko, PJ
    ADVANCED DRUG DELIVERY REVIEWS, 1999, 39 (1-3) : 1 - 3
  • [42] Targeting anti-HIV drugs to the CNS
    Rao, Kavitha S.
    Ghorpade, Anuja
    Labhasetwar, Vinod
    EXPERT OPINION ON DRUG DELIVERY, 2009, 6 (08) : 771 - 784
  • [43] Anti-HIV drugs, profits and politics
    不详
    REPRODUCTIVE HEALTH MATTERS, 2001, 9 (17) : 231 - 231
  • [44] Evolved neural networks for quantitative structure-activity relations hips of Anti-HIV compounds
    Landavazo, D
    Fogel, GB
    CEC'02: PROCEEDINGS OF THE 2002 CONGRESS ON EVOLUTIONARY COMPUTATION, VOLS 1 AND 2, 2002, : 199 - 204
  • [45] Anti-HIV drugs and therapy - Preface
    Ross, TM
    CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (18)
  • [46] In vitro anti-HIV potency of stampidine alone and in combination with standard anti-HIV drugs
    Uckun, FM
    Qazi, S
    Venkatchalam, TK
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2005, 55 (04): : 223 - 231
  • [47] Kinetic study of anti-HIV drugs by thermal decomposition analysis
    Ferreira, B. D. L.
    Araujo, B. C. R.
    Sebastiao, R. C. O.
    Yoshida, M. I.
    Mussel, W. N.
    Fialho, S. L.
    Barbosa, J.
    JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY, 2017, 127 (01) : 577 - 585
  • [48] A mathematical study of combined use of anti-HIV drugs and a mutagen
    Harada, Kouji
    KNOWLEDGE-BASED AND INTELLIGENT INFORMATION & ENGINEERING SYSTEMS 18TH ANNUAL CONFERENCE, KES-2014, 2014, 35 : 1407 - 1415
  • [49] Comparison of the inhibitory activity of anti-HIV drugs on P-glycoprotein
    Storch, Caroline Henrike
    Theile, Dirk
    Lindenmaier, Heike
    Haefeli, Walter Emil
    Weiss, Johanna
    BIOCHEMICAL PHARMACOLOGY, 2007, 73 (10) : 1573 - 1581
  • [50] Anti-HIV activity of quassinoids
    Okano, M
    Fukamiya, N
    Tagahara, K
    Cosentino, M
    Lee, TTY
    MorrisNatschke, S
    Lee, KH
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (06) : 701 - 706